Global Oral Hypoglyceimic Agents (OHAs) Market Insights and Forecast to 2026

Global Oral Hypoglyceimic Agents (OHAs) Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Oral Hypoglyceimic Agents (OHAs) Product Introduction
1.2 Market Segments
1.3 Key Oral Hypoglyceimic Agents (OHAs) Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Oral Hypoglyceimic Agents (OHAs) Market Size Growth Rate by Type
1.4.2 Sulfonylureas
1.4.3 Metformin
1.4.4 Thiazolidinediones
1.4.5 Alpha-Glucosidase Inhibitors
1.5 Market by Application
1.5.1 Global Oral Hypoglyceimic Agents (OHAs) Market Size Growth Rate by Application
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Hypoglyceimic Agents (OHAs) Market Size, Estimates and Forecasts
2.1.1 Global Oral Hypoglyceimic Agents (OHAs) Revenue 2015-2026
2.1.2 Global Oral Hypoglyceimic Agents (OHAs) Sales 2015-2026
2.2 Global Oral Hypoglyceimic Agents (OHAs), Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Oral Hypoglyceimic Agents (OHAs) Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Oral Hypoglyceimic Agents (OHAs) Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Oral Hypoglyceimic Agents (OHAs) Competitor Landscape by Players
3.1 Oral Hypoglyceimic Agents (OHAs) Sales by Manufacturers
3.1.1 Oral Hypoglyceimic Agents (OHAs) Sales by Manufacturers (2015-2020)
3.1.2 Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Manufacturers (2015-2020)
3.2 Oral Hypoglyceimic Agents (OHAs) Revenue by Manufacturers
3.2.1 Oral Hypoglyceimic Agents (OHAs) Revenue by Manufacturers (2015-2020)
3.2.2 Oral Hypoglyceimic Agents (OHAs) Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Oral Hypoglyceimic Agents (OHAs) Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Oral Hypoglyceimic Agents (OHAs) Revenue in 2019
3.2.5 Global Oral Hypoglyceimic Agents (OHAs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Oral Hypoglyceimic Agents (OHAs) Price by Manufacturers
3.4 Oral Hypoglyceimic Agents (OHAs) Manufacturing Base Distribution, Product Types
3.4.1 Oral Hypoglyceimic Agents (OHAs) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Hypoglyceimic Agents (OHAs) Product Type
3.4.3 Date of International Manufacturers Enter into Oral Hypoglyceimic Agents (OHAs) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Oral Hypoglyceimic Agents (OHAs) Market Size by Type (2015-2020)
4.1.1 Global Oral Hypoglyceimic Agents (OHAs) Sales by Type (2015-2020)
4.1.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue by Type (2015-2020)
4.1.3 Oral Hypoglyceimic Agents (OHAs) Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Oral Hypoglyceimic Agents (OHAs) Market Size Forecast by Type (2021-2026)
4.2.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Type (2021-2026)
4.2.3 Oral Hypoglyceimic Agents (OHAs) Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Oral Hypoglyceimic Agents (OHAs) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Oral Hypoglyceimic Agents (OHAs) Market Size by Application (2015-2020)
5.1.1 Global Oral Hypoglyceimic Agents (OHAs) Sales by Application (2015-2020)
5.1.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue by Application (2015-2020)
5.1.3 Oral Hypoglyceimic Agents (OHAs) Price by Application (2015-2020)
5.2 Oral Hypoglyceimic Agents (OHAs) Market Size Forecast by Application (2021-2026)
5.2.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Hypoglyceimic Agents (OHAs) Price Forecast by Application (2021-2026)
6 North America
6.1 North America Oral Hypoglyceimic Agents (OHAs) by Country
6.1.1 North America Oral Hypoglyceimic Agents (OHAs) Sales by Country
6.1.2 North America Oral Hypoglyceimic Agents (OHAs) Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Type
6.3 North America Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Application
7 Europe
7.1 Europe Oral Hypoglyceimic Agents (OHAs) by Country
7.1.1 Europe Oral Hypoglyceimic Agents (OHAs) Sales by Country
7.1.2 Europe Oral Hypoglyceimic Agents (OHAs) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Type
7.3 Europe Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Oral Hypoglyceimic Agents (OHAs) by Region
8.1.1 Asia Pacific Oral Hypoglyceimic Agents (OHAs) Sales by Region
8.1.2 Asia Pacific Oral Hypoglyceimic Agents (OHAs) Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Type
8.3 Asia Pacific Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Application
9 Latin America
9.1 Latin America Oral Hypoglyceimic Agents (OHAs) by Country
9.1.1 Latin America Oral Hypoglyceimic Agents (OHAs) Sales by Country
9.1.2 Latin America Oral Hypoglyceimic Agents (OHAs) Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Type
9.3 Central & South America Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Oral Hypoglyceimic Agents (OHAs) by Country
10.1.1 Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Sales by Country
10.1.2 Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Type
10.3 Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Oral Hypoglyceimic Agents (OHAs) Products Offered
11.1.5 Pfizer Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Description and Business Overview
11.3.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer Oral Hypoglyceimic Agents (OHAs) Products Offered
11.3.5 Bayer Related Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Description and Business Overview
11.4.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Products Offered
11.4.5 Bristol-Myers Squibb Related Developments
11.5 Novonordisk
11.5.1 Novonordisk Corporation Information
11.5.2 Novonordisk Description and Business Overview
11.5.3 Novonordisk Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novonordisk Oral Hypoglyceimic Agents (OHAs) Products Offered
11.5.5 Novonordisk Related Developments
11.6 Sanofi-Aventis
11.6.1 Sanofi-Aventis Corporation Information
11.6.2 Sanofi-Aventis Description and Business Overview
11.6.3 Sanofi-Aventis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Products Offered
11.6.5 Sanofi-Aventis Related Developments
11.7 Servier
11.7.1 Servier Corporation Information
11.7.2 Servier Description and Business Overview
11.7.3 Servier Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Servier Oral Hypoglyceimic Agents (OHAs) Products Offered
11.7.5 Servier Related Developments
11.8 Huadong Medicine
11.8.1 Huadong Medicine Corporation Information
11.8.2 Huadong Medicine Description and Business Overview
11.8.3 Huadong Medicine Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Products Offered
11.8.5 Huadong Medicine Related Developments
11.9 Wanbang Biopharmaceuticals
11.9.1 Wanbang Biopharmaceuticals Corporation Information
11.9.2 Wanbang Biopharmaceuticals Description and Business Overview
11.9.3 Wanbang Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Products Offered
11.9.5 Wanbang Biopharmaceuticals Related Developments
11.10 Double-Crane Pharmaceutical
11.10.1 Double-Crane Pharmaceutical Corporation Information
11.10.2 Double-Crane Pharmaceutical Description and Business Overview
11.10.3 Double-Crane Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Products Offered
11.10.5 Double-Crane Pharmaceutical Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Oral Hypoglyceimic Agents (OHAs) Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Oral Hypoglyceimic Agents (OHAs) Market Estimates and Projections by Region
12.1.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Regions 2021-2026
12.1.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Regions 2021-2026
12.2 North America Oral Hypoglyceimic Agents (OHAs) Market Size Forecast (2021-2026)
12.2.1 North America: Oral Hypoglyceimic Agents (OHAs) Sales Forecast (2021-2026)
12.2.2 North America: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast (2021-2026)
12.2.3 North America: Oral Hypoglyceimic Agents (OHAs) Market Size Forecast by Country (2021-2026)
12.3 Europe Oral Hypoglyceimic Agents (OHAs) Market Size Forecast (2021-2026)
12.3.1 Europe: Oral Hypoglyceimic Agents (OHAs) Sales Forecast (2021-2026)
12.3.2 Europe: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast (2021-2026)
12.3.3 Europe: Oral Hypoglyceimic Agents (OHAs) Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Oral Hypoglyceimic Agents (OHAs) Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Oral Hypoglyceimic Agents (OHAs) Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Oral Hypoglyceimic Agents (OHAs) Market Size Forecast by Region (2021-2026)
12.5 Latin America Oral Hypoglyceimic Agents (OHAs) Market Size Forecast (2021-2026)
12.5.1 Latin America: Oral Hypoglyceimic Agents (OHAs) Sales Forecast (2021-2026)
12.5.2 Latin America: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast (2021-2026)
12.5.3 Latin America: Oral Hypoglyceimic Agents (OHAs) Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Oral Hypoglyceimic Agents (OHAs) Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Oral Hypoglyceimic Agents (OHAs) Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Oral Hypoglyceimic Agents (OHAs) Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Hypoglyceimic Agents (OHAs) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Oral Hypoglyceimic Agents (OHAs) Market Segments
Table 2. Ranking of Global Top Oral Hypoglyceimic Agents (OHAs) Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Oral Hypoglyceimic Agents (OHAs) Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Sulfonylureas
Table 5. Major Manufacturers of Metformin
Table 6. Major Manufacturers of Thiazolidinediones
Table 7. Major Manufacturers of Alpha-Glucosidase Inhibitors
Table 8. Global Oral Hypoglyceimic Agents (OHAs) Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Oral Hypoglyceimic Agents (OHAs) Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Oral Hypoglyceimic Agents (OHAs) Sales by Regions 2015-2020 (K MT)
Table 11. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Regions (2015-2020)
Table 12. Global Oral Hypoglyceimic Agents (OHAs) Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Oral Hypoglyceimic Agents (OHAs) Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Oral Hypoglyceimic Agents (OHAs) Sales Share by Manufacturers (2015-2020)
Table 15. Global Oral Hypoglyceimic Agents (OHAs) Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Oral Hypoglyceimic Agents (OHAs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Hypoglyceimic Agents (OHAs) as of 2019)
Table 17. Oral Hypoglyceimic Agents (OHAs) Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Oral Hypoglyceimic Agents (OHAs) Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Oral Hypoglyceimic Agents (OHAs) Price (2015-2020) (USD/MT)
Table 20. Oral Hypoglyceimic Agents (OHAs) Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Oral Hypoglyceimic Agents (OHAs) Product Type
Table 22. Date of International Manufacturers Enter into Oral Hypoglyceimic Agents (OHAs) Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Hypoglyceimic Agents (OHAs) Sales by Type (2015-2020) (K MT)
Table 25. Global Oral Hypoglyceimic Agents (OHAs) Sales Share by Type (2015-2020)
Table 26. Global Oral Hypoglyceimic Agents (OHAs) Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Oral Hypoglyceimic Agents (OHAs) Revenue Share by Type (2015-2020)
Table 28. Oral Hypoglyceimic Agents (OHAs) Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Oral Hypoglyceimic Agents (OHAs) Sales by Application (2015-2020) (K MT)
Table 30. Global Oral Hypoglyceimic Agents (OHAs) Sales Share by Application (2015-2020)
Table 31. North America Oral Hypoglyceimic Agents (OHAs) Sales by Country (2015-2020) (K MT)
Table 32. North America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Country (2015-2020)
Table 33. North America Oral Hypoglyceimic Agents (OHAs) Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Country (2015-2020)
Table 35. North America Oral Hypoglyceimic Agents (OHAs) Sales by Type (2015-2020) (K MT)
Table 36. North America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 37. North America Oral Hypoglyceimic Agents (OHAs) Sales by Application (2015-2020) (K MT)
Table 38. North America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 39. Europe Oral Hypoglyceimic Agents (OHAs) Sales by Country (2015-2020) (K MT)
Table 40. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Country (2015-2020)
Table 41. Europe Oral Hypoglyceimic Agents (OHAs) Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Country (2015-2020)
Table 43. Europe Oral Hypoglyceimic Agents (OHAs) Sales by Type (2015-2020) (K MT)
Table 44. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 45. Europe Oral Hypoglyceimic Agents (OHAs) Sales by Application (2015-2020) (K MT)
Table 46. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 55. Latin America Oral Hypoglyceimic Agents (OHAs) Sales by Country (2015-2020) (K MT)
Table 56. Latin America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Oral Hypoglyceimic Agents (OHAs) Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Country (2015-2020)
Table 59. Latin America Oral Hypoglyceimic Agents (OHAs) Sales by Type (2015-2020) (K MT)
Table 60. Latin America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 61. Latin America Oral Hypoglyceimic Agents (OHAs) Sales by Application (2015-2020) (K MT)
Table 62. Latin America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 71. Pfizer Corporation Information
Table 72. Pfizer Description and Major Businesses
Table 73. Pfizer Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Pfizer Product
Table 75. Pfizer Recent Development
Table 76. GlaxoSmithKline Corporation Information
Table 77. GlaxoSmithKline Description and Major Businesses
Table 78. GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. GlaxoSmithKline Product
Table 80. GlaxoSmithKline Recent Development
Table 81. Bayer Corporation Information
Table 82. Bayer Description and Major Businesses
Table 83. Bayer Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Bayer Product
Table 85. Bayer Recent Development
Table 86. Bristol-Myers Squibb Corporation Information
Table 87. Bristol-Myers Squibb Description and Major Businesses
Table 88. Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Bristol-Myers Squibb Product
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Novonordisk Corporation Information
Table 92. Novonordisk Description and Major Businesses
Table 93. Novonordisk Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Novonordisk Product
Table 95. Novonordisk Recent Development
Table 96. Sanofi-Aventis Corporation Information
Table 97. Sanofi-Aventis Description and Major Businesses
Table 98. Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Sanofi-Aventis Product
Table 100. Sanofi-Aventis Recent Development
Table 101. Servier Corporation Information
Table 102. Servier Description and Major Businesses
Table 103. Servier Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Servier Product
Table 105. Servier Recent Development
Table 106. Huadong Medicine Corporation Information
Table 107. Huadong Medicine Description and Major Businesses
Table 108. Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Huadong Medicine Product
Table 110. Huadong Medicine Recent Development
Table 111. Wanbang Biopharmaceuticals Corporation Information
Table 112. Wanbang Biopharmaceuticals Description and Major Businesses
Table 113. Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Wanbang Biopharmaceuticals Product
Table 115. Wanbang Biopharmaceuticals Recent Development
Table 116. Double-Crane Pharmaceutical Corporation Information
Table 117. Double-Crane Pharmaceutical Description and Major Businesses
Table 118. Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Double-Crane Pharmaceutical Product
Table 120. Double-Crane Pharmaceutical Recent Development
Table 121. Guangzhou Pharmaceutical Corporation Information
Table 122. Guangzhou Pharmaceutical Description and Major Businesses
Table 123. Guangzhou Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Guangzhou Pharmaceutical Product
Table 125. Guangzhou Pharmaceutical Recent Development
Table 126. Global Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Regions (2021-2026) (K MT)
Table 127. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Country (2021-2026) (K MT)
Table 131. North America: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Country (2021-2026) (K MT)
Table 133. Europe: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Region (2021-2026) (K MT)
Table 135. Asia Pacific: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Country (2021-2026) (K MT)
Table 137. Latin America: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Country (2021-2026) (K MT)
Table 139. Middle East and Africa: Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Oral Hypoglyceimic Agents (OHAs) Players
Table 144. Oral Hypoglyceimic Agents (OHAs) Customers List
Table 145. Oral Hypoglyceimic Agents (OHAs) Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Hypoglyceimic Agents (OHAs) Product Picture
Figure 2. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2020 & 2026
Figure 3. Sulfonylureas Product Picture
Figure 4. Metformin Product Picture
Figure 5. Thiazolidinediones Product Picture
Figure 6. Alpha-Glucosidase Inhibitors Product Picture
Figure 7. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application in 2020 & 2026
Figure 8. Hospitals and Clinics
Figure 9. Others
Figure 10. Oral Hypoglyceimic Agents (OHAs) Report Years Considered
Figure 11. Global Oral Hypoglyceimic Agents (OHAs) Market Size 2015-2026 (US$ Million)
Figure 12. Global Oral Hypoglyceimic Agents (OHAs) Sales 2015-2026 (K MT)
Figure 13. Global Oral Hypoglyceimic Agents (OHAs) Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Region (2015-2020)
Figure 15. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Region in 2019
Figure 16. Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Region (2015-2020)
Figure 17. Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Region in 2019
Figure 18. Global Oral Hypoglyceimic Agents (OHAs) Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Oral Hypoglyceimic Agents (OHAs) Revenue in 2019
Figure 20. Oral Hypoglyceimic Agents (OHAs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Figure 22. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2019
Figure 23. Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Type (2015-2020)
Figure 24. Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Type in 2019
Figure 25. Global Oral Hypoglyceimic Agents (OHAs) Market Share by Price Range (2015-2020)
Figure 26. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Figure 27. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application in 2019
Figure 28. Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Application (2015-2020)
Figure 29. Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Application in 2019
Figure 30. North America Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Country in 2019
Figure 33. North America Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Country in 2019
Figure 34. U.S. Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Oral Hypoglyceimic Agents (OHAs) Market Share by Type in 2019
Figure 39. North America Oral Hypoglyceimic Agents (OHAs) Market Share by Application in 2019
Figure 40. Europe Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Country in 2019
Figure 43. Europe Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Country in 2019
Figure 44. Germany Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Oral Hypoglyceimic Agents (OHAs) Market Share by Type in 2019
Figure 55. Europe Oral Hypoglyceimic Agents (OHAs) Market Share by Application in 2019
Figure 56. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Region in 2019
Figure 59. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Region in 2019
Figure 60. China Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Market Share by Type in 2019
Figure 83. Asia Pacific Oral Hypoglyceimic Agents (OHAs) Market Share by Application in 2019
Figure 84. Latin America Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Country in 2019
Figure 87. Latin America Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Country in

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs